159 related articles for article (PubMed ID: 9060634)
21. Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication.
Freistadt MS; Fleit HB; Wimmer E
Virology; 1993 Aug; 195(2):798-803. PubMed ID: 8393247
[TBL] [Abstract][Full Text] [Related]
22. Blockade of the poliovirus-induced cytopathic effect in neural cells by monoclonal antibody against poliovirus or the human poliovirus receptor.
Yanagiya A; Jia Q; Ohka S; Horie H; Nomoto A
J Virol; 2005 Feb; 79(3):1523-32. PubMed ID: 15650178
[TBL] [Abstract][Full Text] [Related]
23. Polioviruses that bind a chimeric Pvr-nectin-2 protein identify capsid residues involved in receptor interaction.
Lin Y; Racaniello VR
Virology; 2017 Oct; 510():305-315. PubMed ID: 28800489
[TBL] [Abstract][Full Text] [Related]
24. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor.
Mason PW; Baxt B; Brown F; Harber J; Murdin A; Wimmer E
Virology; 1993 Feb; 192(2):568-77. PubMed ID: 8380665
[TBL] [Abstract][Full Text] [Related]
25. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
[TBL] [Abstract][Full Text] [Related]
26. Virus-receptor interaction in poliovirus entry and pathogenesis.
Racaniello VR
Harvey Lect; 1991-1992; 87():1-16. PubMed ID: 1670545
[TBL] [Abstract][Full Text] [Related]
27. Early events in poliovirus infection: virus-receptor interactions.
Racaniello VR
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11378-81. PubMed ID: 8876143
[TBL] [Abstract][Full Text] [Related]
28. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
Harber J; Bernhardt G; Lu HH; Sgro JY; Wimmer E
Virology; 1995 Dec; 214(2):559-70. PubMed ID: 8553558
[TBL] [Abstract][Full Text] [Related]
29. Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor.
Yanagiya A; Ohka S; Hashida N; Okamura M; Taya C; Kamoshita N; Iwasaki K; Sasaki Y; Yonekawa H; Nomoto A
J Virol; 2003 Oct; 77(19):10479-87. PubMed ID: 12970433
[TBL] [Abstract][Full Text] [Related]
30. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
31. The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity.
Gromeier M; Lu HH; Bernhardt G; Harber JJ; Bibb JA; Wimmer E
Ann N Y Acad Sci; 1995 May; 753():19-36. PubMed ID: 7611627
[TBL] [Abstract][Full Text] [Related]
32. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4.
del Fresno C; Otero K; Gómez-García L; González-León MC; Soler-Ranger L; Fuentes-Prior P; Escoll P; Baos R; Caveda L; García F; Arnalich F; López-Collazo E
J Immunol; 2005 Mar; 174(5):3032-40. PubMed ID: 15728517
[TBL] [Abstract][Full Text] [Related]
33. Role of poliovirus receptors in the spread of the infection.
Freistadt MS; Stoltz DA; Eberle KE
Ann N Y Acad Sci; 1995 May; 753():37-47. PubMed ID: 7611646
[TBL] [Abstract][Full Text] [Related]
34. Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells.
Oertli B; Fan X; Wüthrich RP
Nephrol Dial Transplant; 1998 Feb; 13(2):271-8. PubMed ID: 9509434
[TBL] [Abstract][Full Text] [Related]
35. Down regulation of poliovirus receptor RNA in HeLa cells resistant to poliovirus infection.
Kaplan G; Racaniello VR
J Virol; 1991 Apr; 65(4):1829-35. PubMed ID: 1705991
[TBL] [Abstract][Full Text] [Related]
36. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis.
Koike S; Taya C; Aoki J; Matsuda Y; Ise I; Takeda H; Matsuzaki T; Amanuma H; Yonekawa H; Nomoto A
Arch Virol; 1994; 139(3-4):351-63. PubMed ID: 7832641
[TBL] [Abstract][Full Text] [Related]
37. A rapid and sensitive micro scale assay for quantitative detection of cell protective effects: application for the isolation of a monoclonal antibody against HeLa cell proteins involved in poliovirus attachment.
Barnert RH; Zeichhardt H; Habermehl KO
J Virol Methods; 1991 Nov; 35(1):1-14. PubMed ID: 1666110
[TBL] [Abstract][Full Text] [Related]
38. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
[TBL] [Abstract][Full Text] [Related]
39. A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain.
Koike S; Ise I; Sato Y; Yonekawa H; Gotoh O; Nomoto A
J Virol; 1992 Dec; 66(12):7059-66. PubMed ID: 1331508
[TBL] [Abstract][Full Text] [Related]
40. CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins.
Casey RC; Skubitz AP
Clin Exp Metastasis; 2000; 18(1):67-75. PubMed ID: 11206841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
